328
Participants
Start Date
March 29, 2018
Primary Completion Date
September 7, 2023
Study Completion Date
December 1, 2025
Durvalumab
Durvalumab IV (intravenous infusion)
Placebo
Placebo IV (intravenous infusion)
Cisplatin/ Etoposide
Cisplatin/ Etoposide, as per standard of care
Carboplatin/ Paclitaxel
Carboplatin /Paclitaxel, as per standard of care
Pemetrexed/ Cisplatin
Pemetrexed / Cisplatin, as per standard of care
Pemetrexed/ Carboplatin
Pemetrexed / Carboplatin , as per standard of care
Radiation
5 fractions/ week for \~6 weeks (±3 days) (Total 60 Gy)
Research Site, Manila
Research Site, Budapest
Research Site, Budapest
Research Site, Makati
Research Site, City of Taguig
Research Site, Törökbálint
Research Site, Iloilo City
Research Site, Gyula
Research Site, Cebu City
Research Site, Seoul
Research Site, Győr
Research Site, Hanoi
Research Site, Bangkok
Research Site, Bangkok
Research Site, La Libertad
Research Site, Lima
Research Site, Aguascalientes
Research Site, Diyarbakır
Research Site, Chungcheongbuk-do
Research Site, Istanbul
Research Site, Izmir
Research Site, Khon Kaen
Research Site, Guadalajara
Research Site, Busan
Research Site, Mueang
Research Site, Gyeongsangnam-do
Research Site, Hat Yai
Research Site, Orizaba
Research Site, Mérida
Research Site, Hanoi
Research Site, New Delhi
Research Site, Moscow
Research Site, Moscow
Research Site, Gūrgaon
Research Site, Moscow
Research Site, Arkhangelsk
Research Site, Saint Petersburg
Research Site, Rostov-on-Don
Research Site, Karamsad
Research Site, Vadodara
Research Site, Mumbai
Research Site, Nashik
Research Site, Chelyabinsk
Research Site, Bangalore
Research Site, Chennai
Research Site, Omsk
Research Site, Ho Chi Minh City
Research Site, Ribeirão Preto
Research Site, Barretos
Research Site, Curitiba
Research Site, Florianópolis
Research Site, Fortaleza
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Ribeirão Preto
Research Site, São José do Rio Preto
Research Site, São Paulo
Research Site, Brno
Research Site, Ostrava
Research Site, Prague
Research Site, Bunkyō City
Research Site, Fukuoka
Research Site, Kōtoku
Research Site, Kyoto
Research Site, Nagoya
Research Site, Sayama
Research Site, Sendai
Research Site, Yokohama
Research Site, Mexico City
Research Site, México
Research Site, Lima
Research Site, Lima
Research Site, Lima
Research Site, Lima
Research Site, Quezon City
Research Site, Ankara
Research Site, Bydgoszcz
Research Site, Elblag
Research Site, Gdansk
Research Site, Olsztyn
Research Site, Warsaw
Research Site, Seoul
Research Site, Seoul
Research Site, Ankara
Research Site, Antalya
Lead Sponsor
AstraZeneca
INDUSTRY